SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-13-033812
Filing Date
2013-06-10
Accepted
2013-06-10 16:14:10
Documents
2
Period of Report
2013-06-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rrd382969.htm 8-K 12768
2 DYNAVAX REPORTS FEEDBACK FROM FDA MEETING REGARDING HEPLISAV(TM) BIOLOGIC LICENS rrd382969_39658.htm EX-99 7487
  Complete submission text file 0001181431-13-033812.txt   21356
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 13903589
SIC: 2834 Pharmaceutical Preparations